$0.98
+0.01 (+1.11%)
Open$0.96
Previous Close$0.97
Day High$1.00
Day Low$0.96
52W High$3.28
52W Low$1.18
Volume—
Avg Volume1.67M
Market Cap609.85M
P/E Ratio—
EPS$-0.82
SectorPharmaceuticals
Analyst Ratings
Buy
12 analysts
Price Target
+2,303.1% upside
Current
$0.98
$0.98
Target
$23.50
$23.50
$17.63
$23.50 avg
$33.45
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 610.36M | 685.33M | 156.52M |
| Net Income | -563,824,895 | -569,775,887 | 22.40M |
| Profit Margin | -92.4% | -87.8% | 14.3% |
| EBITDA | -335,444,173 | -357,817,161 | 28.04M |
| Free Cash Flow | — | — | 15.05M |
| Rev Growth | -10.9% | -10.9% | +1.7% |
| Debt/Equity | 0.35 | 0.35 | 0.23 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,107.08 | +0.45% | 40.9 | 1.03T |
| JNJ | Johnson & Johnson | $239.08 | +3.37% | 26.1 | 549.78B |
| MRK | Merck & Co. Inc. | $119.60 | +3.57% | 31.5 | 281.24B |
| PFE | Pfizer Inc. | $24.72 | -1.44% | 19.2 | 143.68B |
| BMY | Bristol-Myers Squibb Co | $55.53 | +1.52% | 18.5 | 110.27B |
| ZTS | Zoetis Inc | $76.84 | +1.25% | 12.5 | 33.00B |